Overview

Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma

Status:
Terminated

Trial end date:
2010-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether TAC-101 combined with Transcatheter Arterial Chemoembolization (TACE) is more effective than TACE alone in slowing tumor activity in patients with advanced hepatocellular carcinoma. The study is also looking at the safety of TAC-101 in combination with TACE.

Phase:

Phase 2

Details

Lead Sponsor:

Taiho Oncology, Inc.

Collaborator:

Quintiles, Inc.